
Hims & Hers Revenue Surges 74% as Personalized Care Reaches 70% of Sales
Hims & Hers Health, Inc.Description
What this story covers
Hims & Hers reported explosive 74% nine-month revenue growth, reaching $1.7 billion. Driven by a 21% subscriber increase and a strategic pivot to personalized compounded treatments, the company achieved $107.8 million in net income despite some margin compression.
Story snapshot
CompanyHims & Hers Health, Inc.
TickerHIMS
VariantStandard detailed
Duration13:49
Filing type10-Q
PeriodQ3 2025
IndustryHealthcare & Pharmaceuticals
Accession0001773751-25-000354
Sources1
Full Story Script
Content not available for this story.